USTR-AmbTai-Bilateral-Plurilateal-agreements-3Dec2021 December 3, 2021 Ambassador Katherine Tai Office of the United States Trade Representative Washington, DC Dear Ambassador Tai, On November 18, 2021, Knowledge Ecology International (KEI) provided comments to USTR on three issues that were important for any WTO… Continue Reading
The World Health Assembly’s adoption of a decision [link] to launch intergovernmental negotiations on a WHO pandemic treaty signaled the intent of WHO member states to consider deep consequential reforms in the global pandemic response. KEI is among those who… Continue Reading
On Tuesday, 30 November 2021, Knowledge Ecology International (KEI) delivered the following statement during the special session of the World Health Assembly. Negotiators should address policy failures that have accompanied the current pandemic response, and create a better global framework… Continue Reading
On October 1, 2001, the World Trade Organization (WTO) issued a “Report of the Working Party on the Accession of China.” The 180 page document (WT/ACC/CHN/49) included a discussion of the views of “some members” of the WTO regarding the… Continue Reading
After two weeks of intense negotiations, member states of the World Health Organization (WHO) have finally agreed to compromise text on a decision (The World Together: Establishment of an intergovernmental negotiating body to strengthen pandemic prevention, preparedness and response, SSA2/CONF./1)… Continue Reading
KEI sent this letter to USTR today regarding the TRIPS Waiver negotiations. Highlights what we think are the three most important issues. KEI-USTR-TRIPS-waiver-Priorities-18nov2021 November 18, 2021 Ambassador Katherine Tai Office of the United States Trade Representative Washington, DC Dear Ambassador… Continue Reading
On November 16, 2021, Pfizer and the Medicines Patent Pool (MPP) announced at voluntary license to patented inventions and know-how to manufacture a two drug combination to treat COVID-19. The MPP announcement is here and here. Additional comments on the… Continue Reading
UPDATE: On Friday, 12 November 2021, the draft report of the Member States Working Group on Strengthening WHO Preparedness for and Response to Health Emergencies (WGPR) was published with the document number, A/WGPR/5/2. The report is available here. The fifth… Continue Reading
Update: On 28 October 2021 the Zero Draft Report of the Member States Working Group on Strengthening WHO Preparedness for and Response to Health Emergencies to the special session of the World Health Assembly was published with the Document number… Continue Reading
(For more resources, please see our page on molnupiravir.) The Medicines Patent Pool (MPP) and Merck Sharp & Dohme (“MSD” or “Merck”) have announced a voluntary license for the generic manufacture and sale of molnupiravir. A joint press release from… Continue Reading